Search Login Register

Netherton Syndrome Summary

Description: Rare autosomal recessive disease with variable expressions. Clinical features of the disease include variable ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; bamboo hair (trichorrhexis invaginata); and ATOPIC DERMATITIS. The disease is caused by mutations in the SPINK5 gene.

Also Known As: Disease, Netherton; Syndrome, Netherton; Netherton Disease

Networked: 92 relevant articles (3 outcomes, 3 trials/studies) for this Disease

Key Drugs and Agents for Netherton Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. pimecrolimus (Elidel) : 1 outcome 1 study in 4 results : FDA 2
  2. Serine Proteases (Serine Protease) : 1 study in 35 results : IBA
  3. Tacrolimus (Prograf) : 1 study in 5 results : FDA 7 Generic
  4. Carbon Monoxide : 1 study in 2 results : IBA
  5. Immunoglobulin E (IgE) : 10 results : IBA
  6. Kallikreins (Kallikrein) : 7 results : IBA
  7. Protease Inhibitors (Protease Inhibitor) : 4 results : IBA
  8. Trypsin : 3 results : IBA
  9. Growth Hormone (Somatotropin) : 3 results : IBA
  10. Trichothiodystrophy : 3 results : IBA
Show All >>

Diseases Related to Netherton Syndrome

  1. Skin Diseases
  2. Ichthyosis (Xeroderma)
  3. Atopic Dermatitis (Atopic Eczema)
  4. Lamellar Ichthyosis (Harlequin Ichthyosis)
  5. Genetic Skin Diseases
Show All >>

Key Therapies for Netherton Syndrome

Efficacy Chart >>
  1. Phototherapy (Light Therapy) : 2 outcomes in 3 results
  2. Transplants (Transplant) : 2 results
  3. Extracorporeal Membrane Oxygenation (ECMO) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.